333638801	333638801	CD	B-NP	O
|	|	NNP	I-NP	O
CNHAMC	CNHAMC	NNP	I-NP	O
|	|	VBD	B-VP	O
08202666	08202666	CD	B-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
6272007	6272007	CD	B-NP	O
|	|	CC	I-NP	O
1/24/2006	1/24/2006	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
INFECTED	INFECTED	NNP	I-NP	I-protein
MESH	MESH	NNP	I-NP	I-protein
IN	IN	NNP	I-NP	I-protein
ABDOMINAL	ABDOMINAL	NNP	I-NP	O
|	|	NNP	I-NP	O
Signed	Signed	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
4/17/2006	4/17/2006	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/12/2006	10/12/2006	CD	B-NP	O
ATTENDING	ATTENDING	NN	I-NP	O
:	:	:	O	O
SWEED	SWEED	VBN	B-VP	O
,	,	,	O	O
ZANE	ZANE	NNP	B-NP	O
MD	MD	NNP	I-NP	O
PRINCIPAL	PRINCIPAL	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
:	:	:	O	O
MRSA-infected	MRSA-infected	JJ	B-NP	O
abdominal	abdominal	JJ	I-NP	O
mesh	mesh	NN	I-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
90	90	CD	I-NP	O
+	+	SYM	I-NP	O
-	-	HYPH	I-NP	O
year-old	year-old	JJ	I-NP	O
male	male	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
complex	complex	JJ	I-NP	O
past	past	JJ	I-NP	O
medical	medical	JJ	I-NP	O
history	history	NN	I-NP	O
including	include	VBG	B-PP	O
CAD	CAD	NN	B-NP	B-protein
status	status	NN	I-NP	I-protein
post	post	NN	I-NP	I-protein
stent	stent	JJ	I-NP	I-protein
x2	x2	NN	I-NP	I-protein
,	,	,	O	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
CHF	CHF	NN	B-NP	B-protein
with	with	IN	B-PP	O
an	an	DT	B-NP	O
EF	EF	NN	I-NP	O
of	of	IN	B-PP	O
10-20	10-20	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
AF	AF	NN	B-NP	B-protein
,	,	,	O	O
on	on	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
anticoagulation	anticoagulation	NN	I-NP	O
,	,	,	O	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
pacer	pacer	NN	I-NP	O
placement	placement	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
diabetes	diabetes	NN	B-NP	O
mellitus	mellitus	NN	I-NP	O
who	who	WP	B-NP	O
presented	present	VBD	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
SICU	SICU	NN	I-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
exploratory	exploratory	JJ	I-NP	O
laparotomy	laparotomy	NN	I-NP	O
for	for	IN	B-PP	O
removal	removal	NN	B-NP	O
of	of	IN	B-PP	O
chronically	chronically	RB	B-NP	O
MRSA-infected	MRSA-infected	JJ	I-NP	O
mesh	mesh	NN	I-NP	O
from	from	IN	B-PP	O
prior	prior	JJ	B-NP	O
abdominal	abdominal	JJ	I-NP	O
surgery	surgery	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
ICU	ICU	NN	I-NP	O
for	for	IN	B-PP	O
careful	careful	JJ	B-NP	O
monitoring	monitoring	NN	I-NP	O
and	and	CC	I-NP	O
fluid	fluid	NN	I-NP	O
volume	volume	NN	I-NP	O
management	management	NN	I-NP	O
postoperatively	postoperatively	RB	B-ADVP	O
.	.	.	O	O

He	He	PRP	B-NP	O
has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
multiple	multiple	JJ	B-NP	O
abdominal	abdominal	JJ	I-NP	O
surgeries	surgery	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
mesh	mesh	NN	I-NP	O
was	be	VBD	B-VP	O
originally	originally	RB	I-VP	O
placed	place	VBN	I-VP	O
for	for	IN	B-PP	O
ventral	ventral	JJ	B-NP	O
hernia	hernia	NN	I-NP	O
repair	repair	NN	I-NP	O
in	in	IN	B-PP	O
2005	2005	CD	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
since	since	IN	I-VP	O
developed	develop	VBN	I-VP	O
draining	drain	VBG	I-VP	O
sinus	sinus	NN	B-NP	O
tracts	tract	NNS	I-NP	O
for	for	IN	B-PP	O
which	which	WDT	B-NP	O
cultures	culture	NNS	B-NP	O
have	have	VBP	B-VP	O
grown	grow	VBN	I-VP	O
out	out	RP	B-PRT	O
MRSA	MRSA	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
preoperatively	preoperatively	RB	B-ADVP	O
for	for	IN	B-PP	O
reversal	reversal	NN	B-NP	O
of	of	IN	B-PP	O
anticoagulation	anticoagulation	NN	B-NP	O
and	and	CC	O	O
semi-urgent	semi-urgent	JJ	B-NP	O
removal	removal	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
mesh	mesh	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
operating	operating	NN	I-NP	O
room	room	NN	I-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
underwent	undergo	VBD	B-VP	O
an	an	DT	B-NP	O
exploratory	exploratory	JJ	I-NP	O
laparotomy	laparotomy	NN	I-NP	O
,	,	,	O	O
lysis	lysis	NN	B-NP	O
of	of	IN	B-PP	O
adhesions	adhesion	NNS	B-NP	O
and	and	CC	O	O
removal	removal	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
abdominal	abdominal	JJ	I-NP	O
mesh	mesh	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
closed	close	VBN	I-VP	O
and	and	CC	O	O
one	one	CD	B-NP	O
Jackson-Pratt	Jackson-Pratt	JJ	I-NP	O
drain	drain	NN	I-NP	O
was	be	VBD	B-VP	O
left	leave	VBN	I-VP	O
in	in	IN	B-PP	O
place	place	NN	B-NP	O
.	.	.	O	O

During	During	IN	B-PP	O
the	the	DT	B-NP	O
procedure	procedure	NN	I-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
intubated	intubate	VBN	I-VP	O
with	with	IN	B-PP	O
etomidate	etomidate	NN	B-NP	O
,	,	,	O	O
succinylcholine	succinylcholine	NN	B-NP	O
and	and	CC	O	O
kept	keep	VBD	B-VP	O
sedated	sedate	VBN	I-VP	O
with	with	IN	B-PP	O
Versed	Versed	JJ	B-NP	O
and	and	CC	I-NP	O
fentanyl	fentanyl	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
received	receive	VBD	B-VP	O
intraoperative	intraoperative	JJ	B-NP	O
vancomycin	vancomycin	NN	I-NP	O
and	and	CC	I-NP	O
levofloxacin	levofloxacin	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
2200	2200	CD	B-NP	O
mL	mL	NN	I-NP	O
of	of	IN	B-PP	O
lactated	lactate	VBN	B-VP	O
Ringer	Ringer	NNP	B-NP	O
's	's	POS	B-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
an	an	DT	B-NP	O
attempt	attempt	NN	I-NP	O
to	to	TO	B-VP	O
reverse	reverse	VB	I-VP	O
anticoagulation	anticoagulation	NN	B-NP	O
,	,	,	O	O
one	one	CD	B-NP	O
unit	unit	NN	I-NP	O
of	of	IN	B-PP	O
FFP	FFP	NN	B-NP	B-protein
was	be	VBD	B-VP	O
begun	begin	VBN	I-VP	O
but	but	CC	O	O
then	then	RB	B-VP	O
aborted	abort	VBD	I-VP	O
due	due	IN	B-PP	O
to	to	TO	B-PP	O
hypotension	hypotension	NN	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
resolved	resolve	VBD	B-VP	O
with	with	IN	B-PP	O
epinephrine	epinephrine	NN	B-NP	O
injection	injection	NN	I-NP	O
,	,	,	O	O
likely	likely	RB	B-ADJP	O
due	due	IN	B-PP	O
to	to	TO	B-PP	O
transfusion	transfusion	NN	B-NP	O
reaction	reaction	NN	I-NP	O
.	.	.	O	O

Another	Another	DT	B-NP	O
unit	unit	NN	I-NP	O
of	of	IN	B-PP	O
FFP	FFP	NN	B-NP	B-protein
was	be	VBD	B-VP	O
hung	hang	VBN	I-VP	O
and	and	CC	O	O
tolerated	tolerate	VBN	B-VP	O
well	well	RB	B-ADVP	O
.	.	.	O	O

EBL	EBL	NN	B-NP	B-protein
was	be	VBD	B-VP	O
300	300	CD	B-NP	O
mL	mL	NN	I-NP	O
.	.	.	O	O

Urine	Urine	NN	B-NP	O
output	output	NN	I-NP	O
was	be	VBD	B-VP	O
410	410	CD	B-NP	O
mL	mL	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
four-hour	four-hour	JJ	I-NP	O
case	case	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
extubated	extubate	VBN	I-VP	O
uneventfully	uneventfully	RB	B-ADVP	O
and	and	CC	O	O
transferred	transfer	VBN	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
ICU	ICU	NN	I-NP	B-DNA
in	in	IN	B-PP	O
stable	stable	JJ	B-NP	O
condition	condition	NN	I-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

Colon	Colon	NN	B-NP	O
cancer	cancer	NN	I-NP	O
,	,	,	O	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
colonoscopy	colonoscopy	NN	I-NP	O
in	in	IN	B-PP	O
2005	2005	CD	B-NP	O
that	that	WDT	B-NP	O
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Prostate	Prostate	NN	B-NP	O
cancer	cancer	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

History	History	NN	B-NP	O
of	of	IN	B-PP	O
CVA	CVA	NN	B-NP	B-protein
with	with	IN	B-PP	O
a	a	DT	B-NP	O
left	left	JJ	I-NP	O
occipital	occipital	NN	I-NP	O
infarct	infarct	NN	I-NP	O
thought	think	VBN	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
embolic	embolic	JJ	B-NP	O
phenomenon	phenomenon	NN	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

History	History	NN	B-NP	O
of	of	IN	B-PP	O
TIAs	TIA	NNS	B-NP	B-protein
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Osteoarthritis	Osteoarthritis	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
cervical	cervical	JJ	I-NP	O
spine	spine	NN	I-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Chronic	Chronic	JJ	B-NP	O
atrial	atrial	JJ	I-NP	O
fibrillation	fibrillation	NN	I-NP	O
,	,	,	O	O
on	on	IN	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
for	for	IN	B-PP	O
anticoagulation	anticoagulation	NN	B-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Sick	Sick	NN	B-NP	O
sinus	sinus	NN	I-NP	O
syndrome	syndrome	NN	I-NP	O
,	,	,	O	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
pacer	pacer	NN	I-NP	O
placement	placement	NN	I-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

CAD	CAD	NN	B-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
MI	MI	NN	I-NP	O
in	in	IN	B-PP	O
2005	2005	CD	B-NP	O
,	,	,	O	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
stenting	stenting	NN	I-NP	O
of	of	IN	B-PP	O
LAD	LAD	NN	B-NP	B-protein
and	and	CC	I-NP	O
RCA	RCA	NN	I-NP	B-protein
.	.	.	O	O

9	9	CD	B-NP	O
.	.	.	O	O

CHF	CHF	NN	B-NP	B-protein
.	.	.	O	O

10	10	CD	B-NP	O
Spindle-cell	Spindle-cell	JJ	I-NP	O
tumors	tumor	NNS	I-NP	O
from	from	IN	B-PP	O
lung	lung	NN	B-NP	O
.	.	.	O	O

11	11	CD	B-NP	O
.	.	.	O	O

Hypothyroidism	Hypothyroidism	NN	B-NP	O
.	.	.	O	O

12	12	CD	B-NP	O
.	.	.	O	O

MRSA	MRSA	NN	B-NP	O
wound	wound	NN	I-NP	O
infection/mesh	infection/mesh	JJ	I-NP	O
infection	infection	NN	I-NP	O
.	.	.	O	O

13	13	CD	B-NP	O
.	.	.	O	O

Status	Status	NNP	B-NP	O
post	post	VBD	B-VP	O
Mallory-Weiss	Mallory-Weiss	JJ	B-NP	O
tear	tear	NN	I-NP	O
.	.	.	O	O

14	14	CD	B-NP	O
.	.	.	O	O

Hiatal	Hiatal	JJ	B-NP	O
hernia	hernia	NN	I-NP	O
.	.	.	O	O

15	15	CD	B-NP	O
.	.	.	O	O

Status	Status	NNP	B-NP	O
post	post	NN	I-NP	O
debridement	debridement	NN	I-NP	O
of	of	IN	B-PP	O
skin	skin	NN	B-NP	O
and	and	CC	O	O
subcutaneous	subcutaneous	JJ	B-NP	O
tissue	tissue	NN	I-NP	O
with	with	IN	B-PP	O
partial	partial	JJ	B-NP	O
excision	excision	NN	I-NP	O
of	of	IN	B-PP	O
mesh	mesh	NN	B-NP	O
and	and	CC	I-NP	O
wound	wound	NN	I-NP	O
vac	vac	NN	I-NP	O
on	on	IN	B-PP	O
8/19/05	8/19/05	CD	B-NP	O
16	16	CD	I-NP	O
.	.	.	O	O

Status	Status	NNP	B-NP	O
post	post	NN	I-NP	O
ex	ex	NN	I-NP	O
lap	lap	NN	I-NP	O
ventral	ventral	JJ	I-NP	O
hernia	hernia	NN	I-NP	O
repair	repair	NN	I-NP	O
with	with	IN	B-PP	O
Sepramesh	Sepramesh	NNP	B-NP	O
,	,	,	O	O
2/29/05	2/29/05	CD	B-NP	O
.	.	.	O	O

17	17	CD	B-NP	O
.	.	.	O	O

Status	Status	NNP	B-NP	O
post	post	VBD	B-VP	O
right	right	JJ	B-NP	O
colectomy	colectomy	NN	I-NP	O
in	in	IN	B-PP	O
2002	2002	CD	B-NP	O
complicated	complicate	VBN	B-VP	O
by	by	IN	B-PP	O
fascial	fascial	JJ	B-NP	B-protein
dehiscence	dehiscence	NN	I-NP	I-protein
requiring	require	VBG	B-VP	I-protein
ex	ex	NN	B-NP	I-protein
lap	lap	NN	I-NP	I-protein
and	and	CC	I-NP	O
repair	repair	NN	I-NP	O
of	of	IN	B-PP	O
fascial	fascial	JJ	B-NP	O
dehiscence	dehiscence	NN	I-NP	O
.	.	.	O	O

18	18	CD	B-NP	O
.	.	.	O	O

Status	Status	NNP	B-NP	O
post	post	NN	I-NP	O
prostatectomy	prostatectomy	NN	I-NP	O
.	.	.	O	O

19	19	CD	B-NP	O
.	.	.	O	O

Status	Status	NNP	B-NP	O
post	post	VBD	B-VP	O
right	right	JJ	B-NP	O
VATS	VATS	NNP	I-NP	O
and	and	CC	O	O
wedge	wedge	NN	B-NP	O
resection	resection	NN	I-NP	O
.	.	.	O	O

20	20	CD	B-NP	O
.	.	.	O	O

Status	Status	NNP	B-NP	O
post	post	NN	I-NP	O
fusion	fusion	NN	I-NP	O
of	of	IN	B-PP	O
cervical	cervical	JJ	B-NP	O
spine	spine	NN	I-NP	O
.	.	.	O	O

21	21	CD	B-NP	O
.	.	.	O	O

Status	Status	NNP	B-NP	O
post	post	NN	I-NP	O
TNA	TNA	NN	I-NP	O
.	.	.	O	O

22	22	CD	B-NP	O
.	.	.	O	O

Status	Status	NNP	B-NP	O
post	post	NN	I-NP	O
appendectomy	appendectomy	NN	I-NP	O
.	.	.	O	O

OUTPATIENT	OUTPATIENT	JJ	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Amiodarone	Amiodarone	NN	B-NP	O
200	200	CD	I-NP	O
mg	mg	NN	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Calcium	Calcium	NN	B-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Colace	Colace	NNP	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
by	by	IN	B-PP	O
mouth	mouth	NN	B-NP	B-protein
t.i.d.	t.i.d.	NN	I-NP	I-protein
4	4	CD	I-NP	I-protein
.	.	.	O	O

Coumadin	Coumadin	NN	B-NP	O
alternating	alternate	VBG	B-VP	O
doses	dose	NNS	B-NP	O
of	of	IN	B-PP	O
4	4	CD	B-NP	O
mg	mg	NN	I-NP	O
and	and	CC	O	O
3	3	CD	B-NP	O
mg	mg	NN	I-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Diltiazem	Diltiazem	NNP	B-NP	O
CD	CD	NNP	I-NP	O
360	360	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Aspirin	Aspirin	NN	B-NP	O
81	81	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Folate	Folate	NN	B-NP	O
1	1	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

Lisinopril	Lisinopril	NNP	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

9	9	CD	B-NP	O
.	.	.	O	O

Metamucil	Metamucil	NNP	B-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
10	10	CD	I-NP	O
.	.	.	O	O

Clopidogrel	Clopidogrel	NN	B-NP	O
75	75	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

11	11	CD	B-NP	O
.	.	.	O	O

Potassium	Potassium	NN	B-NP	O
.	.	.	O	O

12	12	CD	B-NP	O
.	.	.	O	O

Protonix	Protonix	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

13	13	CD	B-NP	O
.	.	.	O	O

Simvastatin	Simvastatin	NN	B-NP	O
80	80	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

14	14	CD	B-NP	O
.	.	.	O	O

Synthroid	Synthroid	JJ	B-NP	O
25	25	CD	I-NP	O
mcg	mcg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

15	15	CD	B-NP	O
.	.	.	O	O

Thiamine	Thiamine	NN	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

16	16	CD	B-NP	O
.	.	.	O	O

Metoprolol	Metoprolol	NN	B-NP	O
SR	SR	NN	I-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
17	17	CD	I-NP	O
.	.	.	O	O

Zyprexa	Zyprexa	NN	B-NP	O
2.5	2.5	CD	I-NP	O
mg	mg	NN	I-NP	O
at	at	IN	B-PP	O
bedtime	bedtime	NN	B-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
ALLERGIES	ALLERGIES	NNS	I-NP	O
:	:	:	O	O
Ether	Ether	NN	B-NP	O
.	.	.	O	O

SOCIAL	SOCIAL	JJ	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
alcohol	alcohol	NN	I-NP	O
or	or	CC	I-NP	O
tobacco	tobacco	NN	I-NP	O
use	use	NN	I-NP	O
.	.	.	O	O

Married	Married	NNP	B-NP	O
,	,	,	O	O
lives	live	VBZ	B-VP	O
with	with	IN	B-PP	O
wife	wife	NN	B-NP	O
,	,	,	O	O
retired	retire	VBD	B-VP	O
25	25	CD	B-NP	O
years	year	NNS	I-NP	O
ago	ago	RB	B-ADVP	O
.	.	.	O	O

ADMISSION	ADMISSION	NN	B-NP	O
LABS	LABS	NN	I-NP	O
:	:	:	O	O
Remarkable	Remarkable	JJ	B-ADJP	O
for	for	IN	B-PP	O
creatinine	creatinine	NN	B-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
,	,	,	O	O
hematocrit	hematocrit	NN	B-NP	O
of	of	IN	B-PP	O
30.1	30.1	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
INR	INR	NN	B-NP	B-protein
of	of	IN	B-PP	O
1.7	1.7	CD	B-NP	O
.	.	.	O	O

EKG	EKG	NN	B-NP	O
V-paced	V-paced	JJ	B-ADJP	O
at	at	IN	B-PP	O
60	60	CD	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
ST-T	ST-T	NN	I-NP	O
wave	wave	NN	I-NP	O
abnormalities	abnormality	NNS	I-NP	O
compared	compare	VBN	B-VP	O
to	to	TO	B-VP	O
preop	preop	VB	I-VP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	NNP	B-NP	O
EXAMINATION	EXAMINATION	NNP	I-NP	O
:	:	:	O	O
Vital	Vital	NNP	B-NP	O
Signs	Signs	NNP	I-NP	O
:	:	:	O	O
On	On	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
temperature	temperature	NN	B-NP	O
98	98	CD	I-NP	O
,	,	,	O	O
pulse	pulse	NN	B-NP	O
60	60	CD	I-NP	O
and	and	CC	O	O
V-paced	V-paced	JJ	B-NP	O
,	,	,	I-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
140/85	140/85	CD	I-NP	O
,	,	,	O	O
saturating	saturate	VBG	B-VP	O
96	96	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
3	3	CD	B-NP	O
L	L	NN	I-NP	O
nasal	nasal	JJ	I-NP	O
cannula	cannula	NN	I-NP	O
.	.	.	O	O

Neuro	Neuro	NNP	B-NP	O
:	:	:	O	O
Awake	Awake	NNP	B-NP	O
,	,	,	O	O
alert	alert	JJ	B-NP	O
,	,	,	I-NP	O
appropriate	appropriate	JJ	I-NP	O
.	.	.	O	O

Pulmonary	Pulmonary	NNP	B-NP	O
:	:	:	O	O
Clear	Clear	NNP	B-NP	O
to	to	TO	B-VP	O
auscultation	auscultation	VB	I-VP	O
bilaterally	bilaterally	RB	B-ADVP	O
,	,	,	O	O
no	no	DT	B-NP	O
rales	rale	NNS	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
wheezes	wheeze	NNS	I-NP	O
.	.	.	O	O

Cardiovascular	Cardiovascular	JJ	B-ADJP	O
:	:	:	O	O
Regular	Regular	JJ	B-NP	O
rate	rate	NN	I-NP	O
and	and	CC	I-NP	O
rhythm	rhythm	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
murmurs	murmur	NNS	I-NP	O
,	,	,	I-NP	O
rubs	rub	NNS	I-NP	O
or	or	CC	I-NP	O
gallops	gallop	NNS	I-NP	O
.	.	.	O	O

Abdomen	Abdoman	NNS	B-NP	O
:	:	:	O	O
Soft	Soft	JJ	B-NP	O
,	,	,	I-NP	O
nondistended	nondistended	JJ	I-NP	O
,	,	,	I-NP	O
mildly	mildly	RB	I-NP	O
tender	tender	NN	I-NP	O
midline	midline	NN	I-NP	O
incision	incision	NN	I-NP	O
with	with	IN	B-PP	O
dressing	dress	VBG	B-VP	O
clean	clean	JJ	B-NP	O
,	,	,	I-NP	O
dry	dry	JJ	I-NP	O
and	and	CC	I-ADJP	O
intact	intact	JJ	I-ADJP	O
.	.	.	O	O

JP	JP	NN	B-NP	O
in	in	IN	B-PP	O
midline	midline	NN	B-NP	O
with	with	IN	B-PP	O
sanguinous	sanguinous	JJ	B-NP	O
drainage	drainage	NN	I-NP	O
.	.	.	O	O

Lax	Lax	NN	B-NP	B-protein
abdominal	abdominal	JJ	I-NP	O
wall	wall	NN	I-NP	O
with	with	IN	B-PP	O
protuberance	protuberance	NN	B-NP	O
but	but	CC	O	O
soft	soft	JJ	B-ADJP	O
.	.	.	O	O

Extremities	Extremity	NNS	B-NP	O
:	:	:	O	O
Warm	Warm	NN	B-NP	O
and	and	CC	O	O
well	well	RB	B-ADJP	O
perfused	perfuse	VBN	I-ADJP	O
.	.	.	O	O

IMAGING	IMAGING	NNP	B-NP	O
:	:	:	O	O
Chest	Chest	NNP	B-NP	O
x-ray	x-ray	NN	I-NP	O
negative	negative	JJ	B-ADJP	O
for	for	IN	B-PP	O
acute	acute	JJ	B-NP	O
disease	disease	NN	I-NP	O
and	and	CC	O	O
cardiomegaly	cardiomegaly	NN	B-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
90	90	CD	I-NP	O
+	+	SYM	I-NP	O
-	-	HYPH	I-NP	O
year-old	year-old	JJ	I-NP	O
gentleman	gentleman	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
complex	complex	JJ	I-NP	O
past	past	JJ	I-NP	O
medical	medical	JJ	I-NP	O
history	history	NN	I-NP	O
including	include	VBG	B-PP	O
CAD	CAD	NN	B-NP	B-protein
status	status	NN	I-NP	I-protein
post	post	NN	I-NP	I-protein
MI	MI	NN	I-NP	I-protein
and	and	CC	O	O
stent	stent	JJ	B-NP	B-protein
x2	x2	NN	I-NP	I-protein
,	,	,	O	O
CHF	CHF	NN	B-NP	B-protein
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
SICU	SICU	NN	I-NP	B-DNA
,	,	,	O	O
status	status	NN	B-NP	B-protein
post	post	NN	I-NP	I-protein
ex	ex	NN	I-NP	I-protein
lap	lap	NN	I-NP	I-protein
for	for	IN	B-PP	O
removal	removal	NN	B-NP	O
of	of	IN	B-PP	O
MRSA-infected	MRSA-infected	JJ	B-NP	O
mesh	mesh	NN	I-NP	O
for	for	IN	B-PP	O
careful	careful	JJ	B-NP	O
monitoring	monitoring	NN	I-NP	O
and	and	CC	I-NP	O
fluid	fluid	NN	I-NP	O
resuscitation	resuscitation	NN	I-NP	O
in	in	IN	B-PP	O
light	light	NN	B-NP	O
of	of	IN	B-PP	O
cardiac	cardiac	JJ	B-NP	O
status	status	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
postoperative	postoperative	JJ	I-NP	O
course	course	NN	I-NP	O
was	be	VBD	B-VP	O
remarkable	remarkable	JJ	B-ADJP	O
for	for	IN	B-PP	O
bleeding	bleed	VBG	B-VP	O
with	with	IN	B-PP	O
sanguinous	sanguinous	JJ	B-NP	O
output	output	NN	I-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
JP	JP	NN	I-NP	B-protein
drain	drain	NN	I-NP	I-protein
,	,	,	O	O
a	a	DT	B-NP	O
question	question	NN	I-NP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
abdominal	abdominal	JJ	I-NP	O
hematoma	hematoma	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
progressive	progressive	JJ	I-NP	O
drop	drop	NN	I-NP	O
in	in	IN	B-PP	O
his	his	PRP$	B-NP	O
hematocrit	hematocrit	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
heparin	heparin	NN	I-NP	O
drip	drip	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
initiated	initiate	VBN	I-VP	O
given	give	VBN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
chronic	chronic	JJ	I-NP	O
AF	AF	NN	I-NP	O
,	,	,	O	O
was	be	VBD	B-VP	O
discontinued	discontinue	VBN	I-VP	O
and	and	CC	O	O
FFP	FFP	NN	B-NP	B-protein
administered	administer	VBN	B-VP	O
.	.	.	O	O

Platelets	Platelet	NNS	B-NP	B-cell_type
were	be	VBD	B-VP	O
also	also	RB	I-VP	O
given	give	VBN	I-VP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
request	request	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
Plastic	Plastic	NNP	I-NP	O
Surgery	Surgery	NNP	I-NP	O
Team	Team	NNP	I-NP	O
in	in	IN	B-PP	O
light	light	NN	B-NP	O
of	of	IN	B-PP	O
aspirin	aspirin	NN	B-NP	O
and	and	CC	I-NP	O
Plavix	Plavix	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
were	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
cardiac	cardiac	JJ	I-NP	O
stents	stent	NNS	I-NP	O
.	.	.	O	O

Despite	Despite	IN	B-PP	O
bolus	bolus	NN	B-NP	O
Lasix	Lasix	NNP	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
did	do	VBD	B-VP	O
develop	develop	VB	I-VP	O
CHF	CHF	NN	B-NP	B-protein
with	with	IN	B-PP	O
symptomatic	symptomatic	JJ	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
edema	edema	NN	I-NP	O
and	and	CC	O	O
increased	increase	VBD	B-VP	O
oxygen	oxygen	NN	B-NP	O
requirement	requirement	NN	I-NP	O
.	.	.	O	O

Concomitantly	Concomitantly	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
also	also	RB	B-ADVP	O
became	become	VBD	B-VP	O
delirious	delirious	JJ	B-ADJP	O
,	,	,	O	O
as	as	IN	B-SBAR	O
is	be	VBZ	B-VP	O
his	his	PRP$	B-NP	O
historical	historical	JJ	I-NP	O
pattern	pattern	NN	I-NP	O
with	with	IN	B-PP	O
significant	significant	JJ	B-NP	O
agitation	agitation	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
developed	develop	VBD	B-VP	O
hypertension	hypertension	NN	B-NP	O
refractory	refractory	JJ	B-ADJP	O
to	to	TO	B-PP	O
beta-blockade	beta-blockade	NN	B-NP	O
,	,	,	O	O
calcium	calcium	NN	B-NP	O
channel	channel	NN	I-NP	O
blockers	blocker	NNS	I-NP	O
and	and	CC	O	O
IV	IV	CD	B-NP	O
ACE	ACE	NN	I-NP	O
inhibitors	inhibitor	NNS	I-NP	O
in	in	IN	B-PP	O
this	this	DT	B-NP	O
setting	setting	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
thus	thus	RB	I-VP	O
placed	place	VBN	I-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
nitroglycerin	nitroglycerin	NN	I-NP	B-protein
drip	drip	NN	I-NP	I-protein
,	,	,	O	O
a	a	DT	B-NP	O
furosemide	furosemide	NN	I-NP	O
drip	drip	NN	I-NP	O
with	with	IN	B-PP	O
ginger	ginger	NN	B-NP	O
blood	blood	NN	I-NP	O
product	product	NN	I-NP	O
resuscitation	resuscitation	NN	I-NP	O
to	to	TO	B-VP	O
address	address	VB	I-VP	O
bleeding	bleeding	NN	B-NP	O
and	and	CC	O	O
an	an	DT	B-NP	O
elevated	elevate	VBN	I-NP	O
INR	INR	NN	I-NP	B-protein
.	.	.	O	O

He	He	PRP	B-NP	O
responded	respond	VBD	B-VP	O
well	well	RB	B-ADVP	O
to	to	TO	B-PP	O
this	this	DT	B-NP	O
regimen	regimen	NN	I-NP	O
and	and	CC	O	O
aggressive	aggressive	JJ	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
toilet	toilet	NN	I-NP	O
.	.	.	O	O

Both	Both	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
PCP	PCP	NN	I-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Gillice	Gillice	NNP	I-NP	O
,	,	,	O	O
and	and	CC	O	O
his	his	PRP$	B-NP	O
cardiologist	cardiologist	NN	I-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Keks	Keks	NNP	I-NP	O
,	,	,	O	O
did	do	VBD	B-VP	O
follow	follow	VB	I-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
oxygenation	oxygenation	NN	I-NP	O
never	never	RB	B-ADVP	O
suffered	suffer	VBD	B-VP	O
during	during	IN	B-PP	O
this	this	DT	B-NP	O
time	time	NN	I-NP	O
and	and	CC	O	O
he	he	PRP	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
have	have	VB	I-VP	O
significant	significant	JJ	B-NP	O
hypercarbia	hypercarbia	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
eventually	eventually	RB	I-VP	O
weaned	wean	VBN	I-VP	O
back	back	RB	B-ADVP	O
to	to	TO	B-PP	O
nasal	nasal	JJ	B-NP	O
cannula	cannula	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
did	do	VBD	B-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
mild	mild	JJ	I-NP	O
transient	transient	JJ	I-NP	O
elevation	elevation	NN	I-NP	O
in	in	IN	B-PP	O
creatinine	creatinine	NN	B-NP	O
while	while	IN	B-SBAR	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
Lasix	Lasix	NNP	I-NP	O
drip	drip	NN	I-NP	O
but	but	CC	O	O
has	have	VBZ	B-VP	O
since	since	RB	I-VP	O
recovered	recover	VBN	I-VP	O
back	back	RB	B-ADVP	O
to	to	TO	B-VP	O
baseline	baseline	VB	I-VP	O
off	off	RP	B-PRT	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
Lasix	Lasix	NNP	I-NP	O
drip	drip	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
nasogastric	nasogastric	JJ	I-NP	O
tube	tube	NN	I-NP	O
was	be	VBD	B-VP	O
removed	remove	VBN	I-VP	O
on	on	IN	B-PP	O
5/18/06	5/18/06	CD	B-NP	O
and	and	CC	O	O
he	he	PRP	B-NP	O
tolerated	tolerate	VBD	B-VP	O
ice	ice	NN	B-NP	O
chips	chip	NNS	I-NP	O
without	without	IN	B-PP	O
difficulty	difficulty	NN	B-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
home	home	NN	I-NP	O
cardiac	cardiac	JJ	I-NP	O
medications	medication	NNS	I-NP	O
were	be	VBD	B-VP	O
restarted	restart	VBN	I-VP	O
on	on	IN	B-PP	O
6/10/06	6/10/06	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
out	out	IN	B-PP	O
of	of	IN	B-PP	O
bed	bed	NN	B-NP	O
and	and	CC	O	O
ambulating	ambulate	VBG	B-VP	O
without	without	IN	B-PP	O
difficulty	difficulty	NN	B-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
dictation	dictation	NN	B-NP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
nitroglycerin	nitroglycerin	NN	I-NP	O
drip	drip	NN	I-NP	O
was	be	VBD	B-VP	O
being	be	VBG	I-VP	O
weaned	wean	VBN	I-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
assistance	assistance	NN	I-NP	O
of	of	IN	B-PP	O
nitro	nitro	NN	B-NP	O
paste	paste	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
is	be	VBZ	B-VP	O
anticipated	anticipate	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
transferred	transfer	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
floor	floor	NN	I-NP	O
once	once	IN	B-SBAR	O
he	he	PRP	B-NP	O
receives	receive	VBZ	B-VP	O
a	a	DT	B-NP	O
red	red	JJ	I-NP	O
blood	blood	NN	I-NP	O
cell	cell	NN	I-NP	O
transfusion	transfusion	NN	I-NP	O
and	and	CC	O	O
once	once	RB	B-ADVP	O
the	the	DT	B-NP	O
nitroglycerin	nitroglycerin	NN	I-NP	O
drip	drip	NN	I-NP	O
is	be	VBZ	B-VP	O
off	off	RB	B-ADVP	O
.	.	.	O	O

PLAN	PLAN	NN	B-NP	O
:	:	:	O	O
Neuro	Neuro	NN	B-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
does	do	VBZ	B-VP	O
sundown	sundown	VB	I-VP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
and	and	CC	O	O
has	have	VBZ	B-VP	O
done	do	VBN	I-VP	O
so	so	RB	B-ADVP	O
while	while	IN	B-SBAR	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
ICU	ICU	NN	I-NP	B-DNA
.	.	.	O	O

He	He	PRP	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
much	much	RB	B-ADJP	O
more	more	RBR	I-ADJP	O
calm	calm	JJ	I-ADJP	O
and	and	CC	I-ADJP	O
appropriate	appropriate	JJ	I-ADJP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
past	past	JJ	I-NP	O
24	24	CD	I-NP	O
to	to	TO	I-NP	O
36	36	CD	I-NP	O
hours	hour	NNS	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

He	He	PRP	B-NP	O
does	do	VBZ	B-VP	O
experience	experience	VB	I-VP	O
more	more	RBR	B-NP	O
significant	significant	JJ	I-NP	O
delirium	delirium	NN	I-NP	O
with	with	IN	B-PP	O
morphine	morphine	NN	B-NP	O
and	and	CC	O	O
less	less	JJR	B-NP	O
so	so	RB	B-ADVP	O
with	with	IN	B-PP	O
sparing	spar	VBG	B-VP	B-protein
Dilaudid	Dilaudid	JJ	B-NP	I-protein
p.r.n.	p.r.n.	NN	I-NP	I-protein
3	3	CD	I-NP	I-protein
.	.	.	O	O

We	We	PRP	B-NP	O
will	will	MD	B-VP	O
continue	continue	VB	I-VP	O
with	with	IN	B-PP	O
sparing	spar	VBG	B-VP	O
Dilaudid	Dilaudid	NNP	B-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
Zyprexa	Zyprexa	NN	B-NP	B-protein
2.5	2.5	CD	I-NP	I-protein
at	at	IN	B-PP	O
bedtime	bedtime	NN	B-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
per	per	IN	B-PP	O
home	home	NN	B-NP	O
regimen	regimen	NN	I-NP	O
.	.	.	O	O

Haldol	Haldol	NN	B-NP	O
is	be	VBZ	B-VP	O
written	write	VBN	I-VP	O
p.r.n.	p.r.n.	RB	B-ADVP	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
.	.	.	O	O

Cardiovascular	Cardiovascular	NNP	B-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

CAD	CAD	NN	B-NP	B-protein
status	status	NN	I-NP	I-protein
post	post	NN	I-NP	I-protein
stent	stent	JJ	I-NP	I-protein
x2	x2	NN	I-NP	I-protein
,	,	,	O	O
AF	AF	NN	B-NP	O
on	on	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
anticoagulation	anticoagulation	NN	I-NP	O
,	,	,	O	O
CHF	CHF	NN	B-NP	B-protein
,	,	,	O	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
pacer	pacer	NN	I-NP	O
for	for	IN	B-PP	O
sick	sick	JJ	B-NP	O
sinus	sinus	NN	I-NP	O
syndrome	syndrome	NN	I-NP	O
,	,	,	O	O
currently	currently	RB	B-ADVP	O
V	V	CD	B-NP	O
paced	pace	VBN	B-VP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Outpatient	Outpatient	JJ	B-NP	O
systolic	systolic	JJ	I-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
150	150	CD	B-NP	O
to	to	TO	B-PP	O
180	180	CD	B-NP	O
,	,	,	O	O
current	current	JJ	B-NP	O
goal	goal	NN	I-NP	O
of	of	IN	B-PP	O
SBP	SBP	NN	B-NP	O
140	140	CD	I-NP	O
to	to	TO	B-PP	O
160	160	CD	B-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Weaning	Weaning	NN	B-NP	O
off	off	IN	B-PP	O
nitroglycerin	nitroglycerin	NN	B-NP	O
drip	drip	NN	I-NP	O
,	,	,	O	O
nitro	nitro	NN	B-NP	O
paste	paste	NN	I-NP	O
added	add	VBD	B-VP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Diltiazem	Diltiazem	NNP	B-NP	O
CD	CD	NNP	I-NP	O
360	360	CD	I-NP	O
p.o.	p.o.	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
Lopressor	Lopressor	NNP	B-NP	O
SR	SR	NNP	I-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
lisinopril	lisinopril	NN	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
amiodarone	amiodarone	NN	B-NP	O
200	200	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
restarted	restart	VBD	B-VP	O
per	per	IN	B-PP	O
home	home	NN	B-NP	O
regimen	regimen	NN	I-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Aspirin	Aspirin	NN	B-NP	O
and	and	CC	I-NP	O
Plavix	Plavix	NN	I-NP	O
to	to	TO	B-VP	O
continue	continue	VB	I-VP	O
for	for	IN	B-PP	O
cardiac	cardiac	JJ	B-NP	O
stents	stent	NNS	I-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Watch	Watch	NN	B-NP	O
for	for	IN	B-PP	O
overload	overload	NN	B-NP	O
.	.	.	O	O

Pulmonary	Pulmonary	NNP	B-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

Pulmonary	Pulmonary	JJ	B-NP	O
edema	edema	NN	I-NP	O
with	with	IN	B-PP	O
improving	improve	VBG	B-VP	O
chest	chest	NN	B-NP	O
x-ray	x-ray	NN	I-NP	O
,	,	,	O	O
currently	currently	RB	B-ADVP	O
saturating	saturate	VBG	B-VP	O
well	well	RB	B-ADVP	O
on	on	IN	B-PP	O
4	4	CD	B-NP	O
L	L	NN	I-NP	O
of	of	IN	B-PP	O
nasal	nasal	JJ	B-NP	O
cannula	cannula	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Aggressive	Aggressive	JJ	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
toilet	toilet	NN	I-NP	O
,	,	,	O	O
nebs	neb	NNS	B-NP	O
,	,	,	O	O
out	out	IN	B-PP	O
of	of	IN	B-PP	O
bed	bed	NN	B-NP	O
and	and	CC	I-NP	O
ambulation	ambulation	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Lasix	Lasix	NN	B-NP	O
with	with	IN	B-PP	O
blood	blood	NN	B-NP	O
.	.	.	O	O

GI	GI	LS	B-LST	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
advanced	advance	VBD	B-VP	O
to	to	TO	I-VP	O
clear	clear	VB	I-VP	O
liquids	liquid	NNS	B-NP	O
only	only	RB	B-ADVP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

All	All	DT	B-NP	O
p.o.	p.o.	FW	I-NP	O
meds	med	NNS	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Nexium	Nexium	NN	B-NP	O
.	.	.	O	O

GU	GU	NN	B-NP	B-protein
:	:	:	O	I-protein
1	1	LS	B-LST	I-protein
.	.	.	O	O

Good	Good	JJ	B-NP	O
urine	urine	NN	I-NP	O
output	output	NN	I-NP	O
off	off	IN	B-PP	O
Lasix	Lasix	NNP	B-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Creatinine	Creatinine	NN	B-NP	O
back	back	RB	B-ADVP	O
to	to	TO	B-PP	O
baseline	baseline	NN	B-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Lasix	Lasix	NN	B-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
given	give	VBN	I-VP	O
with	with	IN	B-PP	O
blood	blood	NN	B-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
potassium	potassium	NN	B-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Slowly	Slowly	RB	B-ADVP	O
trending	trend	VBG	B-VP	O
back	back	RB	B-ADVP	O
to	to	TO	B-VP	O
preop	preop	VB	I-VP	O
weight	weight	NN	B-NP	O
,	,	,	O	O
would	would	MD	B-VP	O
recommend	recommend	VB	I-VP	O
gentle	gentle	JJ	B-NP	O
diuresis	diuresis	NN	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
and	and	CC	O	O
careful	careful	JJ	B-NP	O
observance	observance	NN	I-NP	O
of	of	IN	B-PP	O
potassium	potassium	NN	B-NP	O
.	.	.	O	O

Heme	Heme	NNP	B-NP	B-protein
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

Hematocrit	Hematocrit	NN	B-NP	O
25	25	CD	B-NP	O
%	%	NN	I-NP	O
today	today	NN	B-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
will	will	MD	B-VP	O
give	give	VB	I-VP	O
one	one	CD	B-NP	O
unit	unit	NN	I-NP	O
of	of	IN	B-PP	O
packed	packed	JJ	B-NP	B-cell_type
red	red	JJ	I-NP	I-cell_type
blood	blood	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
with	with	IN	B-PP	O
Lasix	Lasix	NN	B-NP	O
and	and	CC	I-NP	O
potassium	potassium	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Continue	Continue	VB	B-VP	O
with	with	IN	B-PP	O
subcutaneous	subcutaneous	JJ	B-NP	O
heparin	heparin	NN	I-NP	O
for	for	IN	B-PP	O
now	now	RB	B-NP	O
and	and	CC	O	O
Coumadin	Coumadin	NN	B-NP	O
to	to	TO	B-VP	O
restart	restart	VB	I-VP	O
at	at	IN	B-PP	O
discretion	discretion	NN	B-NP	O
of	of	IN	B-PP	O
primary	primary	JJ	B-NP	O
team	team	NN	I-NP	O
.	.	.	O	O

ID	ID	NN	B-NP	B-protein
:	:	:	O	I-protein
1	1	LS	B-LST	I-protein
.	.	.	O	O

Vancomycin	Vancomycin	NN	B-NP	O
for	for	IN	B-PP	O
MRSA-infected	MRSA-infected	JJ	B-NP	O
mesh	mesh	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

PICC	PICC	NN	B-NP	O
line	line	NN	I-NP	O
consult	consult	NN	I-NP	O
ordered	order	VBN	B-VP	O
for	for	IN	B-PP	O
anticipated	anticipated	JJ	B-NP	B-protein
long-term	long-term	JJ	I-NP	I-protein
vancomycin	vancomycin	NN	I-NP	I-protein
.	.	.	O	O

Endocrine	Endocrine	JJ	B-ADJP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Synthroid	Synthroid	JJ	B-ADJP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
dose	dose	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

RISS	RISS	NN	B-NP	O
.	.	.	O	O

SERVICES	SERVICES	NNS	B-NP	O
FOLLOWING	FOLLOWING	VBG	B-VP	O
THE	THE	DT	B-NP	O
PATIENT	PATIENT	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Medicine	Medicine	NNP	B-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Harcar	Harcar	NNP	I-NP	O
,	,	,	O	O
patient	patient	NN	B-NP	O
's	's	POS	B-NP	O
PCP	PCP	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Cardiology	Cardiology	NNP	B-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Pagliari	Pagliari	NNP	I-NP	O
3	3	CD	I-NP	O
.	.	.	O	O

Plastic	Plastic	NNP	B-NP	O
Surgery	Surgery	NNP	I-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Dunshie	Dunshie	NNP	I-NP	O
Patient	Patient	NNP	I-NP	O
anticipated	anticipate	VBD	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
transferred	transfer	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
floor	floor	NN	I-NP	O
on	on	IN	B-PP	O
6/10/06	6/10/06	CD	B-NP	O
.	.	.	O	O

eScription	eScription	NN	B-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
8-8285601	8-8285601	CD	B-NP	O
CSSten	CSSten	NNP	I-NP	O
Tel	Tel	NNP	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
POSSINGER	POSSINGER	NN	B-NP	O
,	,	,	O	O
NICK	NICK	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
BERKELEY	BERKELEY	NNP	B-NP	O
,	,	,	O	O
MURRAY	MURRAY	NNP	B-NP	O
Dictation	Dictation	NNP	I-NP	O
ID	ID	NNP	I-NP	O
6945290	6945290	CD	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
9/22/06	9/22/06	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
9/22/06	9/22/06	CD	B-NP	O

